![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Salvador Javier Gomez-Ambrosi Javier Frühbeck Gema
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.2, Iss.10, 2001-10, pp. : 1615-1622
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The therapeutic potential of leptin
By Proietto Joseph Thorburn Anne W
Expert Opinion on Investigational Drugs, Vol. 12, Iss. 3, 2003-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Shp2 as a therapeutic target for leptin resistance and obesity
Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 1, 2006-02 ,pp. :